Characterization of monoclonal antibodies against human parvovirus B19

Microbiol Immunol. 1989;33(7):561-7. doi: 10.1111/j.1348-0421.1989.tb02006.x.

Abstract

Eleven hybridoma cell lines producing mouse monoclonal antibodies (mAbs) against human parvovirus B19 were established. Their specificity was as follows. Approximately 5% of fetal erythroid cells inoculated with B19 reacted with all the mAbs and with anti-B19 positive human serum, but not with negative serum by indirect double immunofluorescence staining. All the mAbs recognized both VP-1 (84 kDa) and VP-2 (58 kDa) capsid proteins of B19 virions propagated in vitro and in vivo by Western blotting, and immunoprecipitated B19 virions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis*
  • Antibodies, Monoclonal / immunology
  • Antibodies, Viral / biosynthesis*
  • Antibodies, Viral / immunology
  • Antibody Specificity
  • Blotting, Southern
  • Blotting, Western
  • DNA, Viral / analysis
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique
  • Hybridomas
  • Mice
  • Parvoviridae / immunology*
  • Precipitin Tests
  • Virion / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • DNA, Viral